ACELYRIN, INC. Common Stock Cash Flow-to-Debt Ratio
ACELYRIN, INC. Common Stock cash flow-to-debt ratio. ACELYRIN, INC. Common Stock (SLRN) has a Cash Flow-to-Debt Ratio of -1.33x as of March 2025, meaning its operating cash flow of $-38.95 Million could theoretically repay -1% of its total liabilities ($29.27 Million) in one year. See ACELYRIN, INC. Common Stock (SLRN) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ACELYRIN, INC. Common Stock (2021–2024)
Cash flow-to-debt ratio of ACELYRIN, INC. Common Stock from 2021 to 2024. Historical debt coverage capacity for ACELYRIN, INC. Common Stock across 4 annual periods. Also explore ACELYRIN, INC. Common Stock equity growth rate to track the company's year-over-year net asset growth rate.
ACELYRIN, INC. Common Stock Cash Flow-to-Debt Ratio by Year (2021–2024)
ACELYRIN, INC. Common Stock cash flow-to-debt ratio by year from 2021 to 2024. Year-by-year debt coverage analysis for ACELYRIN, INC. Common Stock. For the full cash flow conversion analysis, see cash efficiency ratio of ACELYRIN, INC. Common Stock.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -9.25x | $-303.92 Million | $32.85 Million | ▼ -370.8% |
| 2023 | -1.97x | $-169.71 Million | $86.35 Million | ▼ -1319.5% |
| 2022 | -0.14x | $-61.52 Million | $444.35 Million | ▼ -301.4% |
| 2021 | -0.03x | $-4.98 Million | $144.36 Million | — |